⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001475720

Viveash Dawn

Reports to the SEC for 1 company · LA JOLLA, CA

Transactions

15

Companies

1

Filings

7

CIK

0001475720

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-07-25	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+382K sh	—	—	382,000
2011-07-22	Orexigen Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−200K sh	—	—	0
2011-07-22	Orexigen Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−30K sh	—	—	0
2011-07-22	Orexigen Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−35K sh	—	—	0
2011-07-22	Orexigen Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−45K sh	—	—	0
2011-07-22	Orexigen Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−72K sh	—	—	0
2011-06-10	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+72K sh	—	—	72,000
2011-03-02	Orexigen Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−45K sh	—	—	0
2011-03-02	Orexigen Therapeutics, Inc.Employee Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+45K sh	—	—	45,000
2011-03-02	Orexigen Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	SVP/Head of Regulatory Affairs	DDisposition to Issuer	−35K sh	—	—	0
2011-03-02	Orexigen Therapeutics, Inc.Employee Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+35K sh	—	—	35,000
2011-01-18	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+35K sh	—	—	35,000
2010-09-20	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+45K sh	—	—	45,000
2010-01-22	Orexigen Therapeutics, Inc.Stock option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+30K sh	—	—	30,000
2009-11-02	Orexigen Therapeutics, Inc.Stock Option (right to buy)A Award	SVP/Head of Regulatory Affairs	AAward	+200K sh	—	—	200,000

Recent filings

7

Accepted (ET)
Jul 264
Viveash Dawn0001181431-11-042487
SEC(opens sec.gov)
Jun 144
Viveash Dawn0001181431-11-036552
SEC(opens sec.gov)
Mar 44
Viveash Dawn0001181431-11-015856
SEC(opens sec.gov)
Jan 204
Viveash Dawn0001181431-11-004495
SEC(opens sec.gov)
Sep 224
Viveash Dawn0001181431-10-047676
SEC(opens sec.gov)
Jan 264
Viveash Dawn0001181431-10-004795
SEC(opens sec.gov)
Nov 44
Viveash Dawn0001181431-09-050010
SEC(opens sec.gov)

Companies

1

Orexigen Therapeutics, Inc.SVP/Head of Regulatory Affairs

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037